Phase II randomized preoperative window of opportunity study of the PI3K inhibitor Pictilisib plus Anastrozole compared with Anastrozole alone in patients with oestrogen receptor-positive breast cancer

Peter Schmid, Sarah E Pinder, Duncan Wheatley, Jane Macaskill, Charles Zammit, Jennifer Hu, Robert Price, Nigel Bundred, Sirwan Hadad, Alice Shia, Shah-Jalal Sarker, Louise Lim, Patrycja Gazinska, Natalie Woodman, Darren Korbie, Matt Trau, Paul Mainwaring, Steve Gendreau, Mark Lackner, Tim WilsonHannah Butler, Gemma Earl, Peter Parker, Arnie Purushotham, Alastair Thompson

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    JournalJournal of Clinical Oncology
    DOIs
    Publication statusPublished - 2015

    Cite this